Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma (Q38904799)

7 September 2017

Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma (English)

1 reference

7 September 2017

Y Gui

1

1 reference

7 September 2017

M Yeganeh

2

1 reference

7 September 2017

Y-C Donates

3

1 reference

7 September 2017

W-S Tobelaim

4

1 reference

7 September 2017

W Chababi

5

1 reference

7 September 2017

M Mayhue

6

1 reference

7 September 2017

A Yoshimura

7

1 reference

7 September 2017

S Ramanathan

8

1 reference

7 September 2017

C Saucier

9

1 reference

7 September 2017

S Ilangumaran

10

1 reference

7 September 2017

language of work or name

English

0 references

publication date

2 March 2015

1 reference

7 September 2017

1 reference

7 September 2017

34

1 reference

7 September 2017

46

1 reference

7 September 2017

5718-5728

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2015.20

7 September 2017

0 references

cites work

SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

SOCS proteins in regulation of receptor tyrosine kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

SOCS1 controls liver regeneration by regulating HGF signaling in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Drug development of MET inhibitors: targeting oncogene addiction and expedience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

MET signalling: principles and functions in development, organ regeneration and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Oncogenic activation of the Met receptor tyrosine kinase fusion protein, Tpr-Met, involves exclusion from the endocytic degradative pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Dorsal ruffle microdomains potentiate Met receptor tyrosine kinase signaling and down-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Down-regulation of MET, the receptor for hepatocyte growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Are SOCS suppressors, regulators, and degraders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

The Role of Elongin BC-Containing Ubiquitin Ligases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Demonstration of cooperative contribution of MET- and EGFR-mediated STAT3 phosphorylation to liver regeneration by exogenous suppressor of cytokine signalings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Regulation of the immune system by SOCS family adaptor proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

ErbB2 stabilizes epidermal growth factor receptor (EGFR) expression via Erk and Sprouty2 in extracellular matrix-detached cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

The ubiquitination code: a signalling problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Identification of miR-30d as a novel prognostic maker of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Spatial regulation of receptor tyrosine kinases in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Targeting MET as a strategy to overcome crosstalk-related resistance to EGFR inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Receptor tyrosine kinase coactivation networks in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Targeting MET in cancer: rationale and progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

From Tpr-Met to Met, tumorigenesis and tubes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

The von Hippel-Lindau tumor suppressor protein promotes c-Cbl-independent poly-ubiquitylation and degradation of the activated EGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

A cytokine-mediated link between innate immunity, inflammation, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Targeting the HGF/c-MET pathway in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Aberrant DNA methylation as a cancer-inducing mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

A positive regulatory role for suppressor of cytokine signaling 1 in IFN-gamma-induced MHC class II expression in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

Suppressors of cytokine signalling (SOCS) in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.20

SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25728680

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Receptor chimeras indicate that the met tyrosine kinase mediates the motility and morphogenic responses of hepatocyte growth/scatter factor.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25728680

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

SOCS, inflammation, and cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25728680

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/ONC.2015.20

1 reference

Dimensions Publication ID

7 September 2017

0 references

1 reference